The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
分析師觀點：在6位專家眼中的Ionis Pharmaceuticals
6 analysts have expressed a variety of opinions on Ionis Pharmaceuticals (NASDAQ:IONS) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.67, a high estimate of $77.00, and a low estimate of $60.00. A decline of 3.18% from the prior average price target is evident in the current average.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間